22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release
here
Home
About Us
Our Company
Our Leadership Team
Board of Directors
Reduced Nicotine Tobacco
VLN®
Clinical Studies & Commentaries
Hemp/Cannabis Innovation
GVB Biopharma
Hops Research
News
Investors
Overview
New Investor / Latest Resources
Events
News
Stock Data
SEC Filings
Analyst Coverage
Corporate Governance
Annual Reports
FAQs
Contact Us
SEC Filings
Investors
Investors
Overview
New Investor / Latest Resources
Events
News
Press Releases
Stock Data
Quote
Charts
Historical Data
Trades
SEC Filings
Analyst Coverage
Corporate Governance
Annual Reports
FAQs
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10QSB
25
3
3/A
4
4/A
424B3
424B5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERT
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
UPLOAD
Year:
View All
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Date
Form
Description
PDF
XBRL
Pages
08/03/22
3
Initial statement of beneficial ownership of securities
Documents
EX-24.1
2
07/29/22
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
7
07/25/22
8-K
Current report filing
Documents
EX-4.1
EX-5.1
EX-10.1
EX-99.1
EX-99.2
29
07/22/22
424B5
Prospectus filed pursuant to Rule 424(b)(5)
40
07/20/22
8-K/A
Current report filing
Documents
EX-23.1
EX-99.1
EX-99.2
EX-99.3
34
06/21/22
8-K
Current report filing
2
06/16/22
4
Statement of changes in beneficial ownership of securities
2
06/15/22
8-K
Current report filing
Documents
EX-10.1
EX-99.1
9
05/27/22
D/A
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
05/25/22
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
Previous
1
2
3
4
5
6
7
8
9
10
…64
Next
Email Alerts
Contact
RSS News Feed